Osimertinib for EGFR-Positive NSCLC Patients with Leptomeningeal Metastases Harboring T790M-Positive or T790M-Negative Mutations-MedSci.cn - 梅斯（MedSci）

Osimertinib for EGFR-Positive NSCLC Patients with Leptomeningeal Metastases Harboring T790M-Positive or T790M-Negative Mutations

Xu, H; Zhang, Y; Kong, J; Yang, G; Yang, L; Liu, S; Wang, Y

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (3): S612

科室
- - 订阅+
  - 更多科室
工具
服务